You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

Metoprolol tartrate - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for metoprolol tartrate and what is the scope of freedom to operate?

Metoprolol tartrate is the generic ingredient in two branded drugs marketed by Novartis, Am Regent, Baxter Hlthcare Corp, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hikma Farmaceutica, Hospira, Luitpold, Sandoz, Steriscience, Watson Labs, Validus Pharms, Alembic Pharms Ltd, Apothecon, Aurobindo Pharma, Chartwell Rx, Heritage Pharma, Ipca Labs Ltd, Mylan, Purepac Pharm, Renata, Rubicon, Sun Pharm Inds Inc, Sun Pharm Industries, Teva, Teva Pharms, Youngtech Pharms Inc, and Zydus Pharms, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-seven drug master file entries for metoprolol tartrate. Fifty-three suppliers are listed for this compound.

Summary for metoprolol tartrate

US Patents:	0
Tradenames:	2
Applicants:	29
NDAs:	35
Drug Master File Entries:	27
Finished Product Suppliers / Packagers:	53
Raw Ingredient (Bulk) Api Vendors:	109
Clinical Trials:	25
Patent Applications:	2,709
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for metoprolol tartrate
Drug Sales Revenues:	Drug sales revenues for metoprolol tartrate
What excipients (inactive ingredients) are in metoprolol tartrate?	metoprolol tartrate excipients list
DailyMed Link:	metoprolol tartrate at DailyMed

See drug prices for metoprolol tartrate

Drug Sales Revenue Trends for metoprolol tartrate

See drug sales revenues for metoprolol tartrate

Recent Clinical Trials for metoprolol tartrate

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
European Commission	Phase 3
Consorcio Centro de Investigación Biomédica en Red (CIBER)	Phase 3
Instituto de Salud Carlos III	Phase 3

See all metoprolol tartrate clinical trials

Pharmacology for metoprolol tartrate

Drug Class	beta-Adrenergic Blocker
Mechanism of Action	Adrenergic beta-Antagonists

US Patents and Regulatory Information for metoprolol tartrate

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hospira	METOPROLOL TARTRATE	metoprolol tartrate	INJECTABLE;INJECTION	074133-001	Dec 21, 1993	AP	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Mylan	METOPROLOL TARTRATE	metoprolol tartrate	TABLET;ORAL	073666-002	Dec 21, 1993		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Zydus Pharms	METOPROLOL TARTRATE	metoprolol tartrate	TABLET;ORAL	212402-002	Apr 19, 2023		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Purepac Pharm	METOPROLOL TARTRATE	metoprolol tartrate	TABLET;ORAL	074380-001	Jul 29, 1994		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Rubicon	METOPROLOL TARTRATE	metoprolol tartrate	TABLET;ORAL	200981-002	Oct 28, 2014	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Aurobindo Pharma	METOPROLOL TARTRATE	metoprolol tartrate	TABLET;ORAL	077739-005	Dec 7, 2023	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Teva	METOPROLOL TARTRATE	metoprolol tartrate	TABLET;ORAL	074143-002	Sep 30, 1994		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for metoprolol tartrate

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Validus Pharms	LOPRESSOR	metoprolol tartrate	TABLET;ORAL	017963-001	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
Validus Pharms	LOPRESSOR	metoprolol tartrate	TABLET;ORAL	017963-001	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
Validus Pharms	LOPRESSOR	metoprolol tartrate	TABLET;ORAL	017963-002	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
Novartis	LOPRESSOR	metoprolol tartrate	INJECTABLE;INJECTION	018704-001	Mar 30, 1984	⤷ Try a Trial	⤷ Try a Trial
Validus Pharms	LOPRESSOR	metoprolol tartrate	TABLET;ORAL	017963-002	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
Novartis	LOPRESSOR	metoprolol tartrate	INJECTABLE;INJECTION	018704-001	Mar 30, 1984	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.